8-KShareholder Matters

Cencora, Inc. 8-K Report, Shareholder Vote Results (Mar 2, 2018)

Filed March 2, 2018For Securities:COR

Summary

This 8-K filing from Cencora, Inc. (formerly AmerisourceBergen Corporation) details the outcomes of its 2018 Annual Meeting of Stockholders, held on March 1, 2018. The key takeaway for investors is the strong shareholder support for the company's board of directors and executive compensation, as well as the ratification of its independent auditor. Conversely, several significant stockholder proposals, including those concerning board independence, special meeting thresholds, executive compensation clawbacks, and opioid-related governance, did not receive majority approval from shareholders. This indicates a general alignment between management and a significant portion of its shareholder base on strategic and governance matters, with a clear rejection of certain shareholder-led initiatives. Specifically, all director nominees were overwhelmingly elected, and the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2018 was ratified. Additionally, shareholders provided advisory approval for the compensation of named executive officers and approved an amendment to the company's stock purchase plan. The results suggest that while the board and management are generally favored, there is a segment of shareholders advocating for changes in corporate governance structures and policies, as evidenced by the voting patterns on the various proposals.

Key Highlights

  • 1All director nominees were overwhelmingly elected at the 2018 Annual Meeting of Stockholders.
  • 2Stockholders ratified the appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2018.
  • 3An advisory vote to approve the compensation of the Company's Named Executive Officers received majority shareholder approval.
  • 4The AmerisourceBergen Corporation 2011 Employment Stock Purchase Plan was amended and restated with shareholder approval.
  • 5A stockholder proposal to establish an independent Chairman of the Board was not approved.
  • 6Stockholder proposals regarding the ownership threshold for calling special meetings, disclosure of incentive compensation clawbacks, and governance measures related to opioids all failed to gain majority approval.

Frequently Asked Questions

The 2018 Annual Meeting saw the election of all director nominees, ratification of the independent auditor (Ernst & Young LLP), advisory approval of executive compensation, and approval of an amendment to the company's stock purchase plan. However, several significant shareholder proposals related to board independence, special meetings, compensation clawbacks, and opioid governance did not pass.

Shareholders provided advisory approval for the compensation of the Company's Named Executive Officers. However, a proposal to urge the Board to adopt a policy to disclose certain incentive compensation clawbacks was not approved, indicating a mixed sentiment or a preference for the existing compensation structure and disclosure policies.

While all director nominees were elected with strong support, a shareholder proposal advocating for an independent Chairman of the Board did not receive majority approval. Similarly, proposals related to special meeting thresholds, incentive compensation clawbacks, and opioid governance measures also failed to pass, suggesting that a majority of shareholders were not in favor of these specific governance changes at that time.

For most approved items, such as director elections and auditor ratification, the 'For' votes significantly outweighed the 'Against' votes, with minimal abstentions or broker non-votes. For instance, the ratification of Ernst & Young LLP saw overwhelming support. The advisory vote on executive compensation also had a substantial margin in favor, though with a notable number of 'Against' votes compared to other approved items.